Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10578981rdf:typepubmed:Citationlld:pubmed
pubmed-article:10578981lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10578981lifeskim:mentionsumls-concept:C0086610lld:lifeskim
pubmed-article:10578981lifeskim:mentionsumls-concept:C0333343lld:lifeskim
pubmed-article:10578981lifeskim:mentionsumls-concept:C0013687lld:lifeskim
pubmed-article:10578981lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:10578981lifeskim:mentionsumls-concept:C0205183lld:lifeskim
pubmed-article:10578981pubmed:issue6lld:pubmed
pubmed-article:10578981pubmed:dateCreated1999-12-14lld:pubmed
pubmed-article:10578981pubmed:abstractTextDetecting malignant cells in the setting of reactive mesothelium can be difficult. Several techniques have been tried but without widespread acceptance. Sialosyl-Tn (STn) is an aberrantly glycosylated precursor of the MN blood group antigen frequently expressed in carcinomas and dysplastic epithelium. We investigated the STn monoclonal antibody for its clinical utility as an isolated stain to discriminate benign mesothelium from malignant cells.lld:pubmed
pubmed-article:10578981pubmed:languageenglld:pubmed
pubmed-article:10578981pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10578981pubmed:citationSubsetIMlld:pubmed
pubmed-article:10578981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10578981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10578981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10578981pubmed:statusMEDLINElld:pubmed
pubmed-article:10578981pubmed:issn0001-5547lld:pubmed
pubmed-article:10578981pubmed:authorpubmed-author:ZimmermanR...lld:pubmed
pubmed-article:10578981pubmed:authorpubmed-author:BibboMMlld:pubmed
pubmed-article:10578981pubmed:authorpubmed-author:FogoAAlld:pubmed
pubmed-article:10578981pubmed:issnTypePrintlld:pubmed
pubmed-article:10578981pubmed:volume43lld:pubmed
pubmed-article:10578981pubmed:ownerNLMlld:pubmed
pubmed-article:10578981pubmed:authorsCompleteYlld:pubmed
pubmed-article:10578981pubmed:pagination1079-84lld:pubmed
pubmed-article:10578981pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:meshHeadingpubmed-meshheading:10578981...lld:pubmed
pubmed-article:10578981pubmed:articleTitleDiagnostic utility of sialosyl-Tn in discriminating carcinomatous cells from benign mesothelium in body cavity effusions.lld:pubmed
pubmed-article:10578981pubmed:affiliationDepartment of Pathology, University of Pennsylvania Health System, Philadelphia, USA. robertz@mail.med.upenn.edulld:pubmed
pubmed-article:10578981pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10578981pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10578981pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10578981lld:pubmed